Is HDGHF or JNJ a better dividend investment in 2026?

HDGHF currently yields 68965.52% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: HDGHF offers higher current income.

What is the dividend yield difference between HDGHF and JNJ?

HDGHF has a forward dividend yield of 68965.52% ($2.00/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 68963.39 percentage points.

Home › Compare › HDGHF vs JNJ

HDGHF vs JNJ: Dividend Comparison 2026

HDGHF yields 68965.52% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 HDGHF wins by $1.1839933886478554e+25M in total portfolio value

INVESTMENT

TIME HORIZON10 years

HDGHF

● Live price

68965.52%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.1839933886478554e+25M

Annual income

$11,806,258,076,409,250,000,000,000,000,000.00

Full HDGHF calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — HDGHF vs JNJ

📍 HDGHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	HDGHF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, HDGHF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

HDGHF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HDGHF

Annual income on $10K today (after 15% tax)

$5,862,068.97/yr

After 10yr DRIP, annual income (after tax)

$10,035,319,364,947,863,000,000,000,000,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, HDGHF beats the other by $10,035,319,364,947,863,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HDGHF + JNJ for your $10,000?

HDGHF: 50%JNJ: 50%

100% JNJ50/50100% HDGHF

Portfolio after 10yr

$5.919966943239277e+24M

Annual income

$5,903,129,038,204,625,000,000,000,000,000.00/yr

Blended yield

99.72%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

HDGHF

No analyst data

Altman Z

-19.8

Piotroski

3/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HDGHF buys

JNJ buys

No recent congressional trades found for HDGHF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricHDGHFJNJ

Forward yield	68965.52% ✓	2.13%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$1.1839933886478554e+25M	$30.3K ✓
Annual income after 10y	$11,806,258,076,409,250,000,000,000,000,000.00 ✓	$4,689.40
Total dividends collected	$1.1837725309237889e+25M	$15.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: HDGHF vs JNJ ($10,000, DRIP)

Year	HDGHF Portfolio	HDGHF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$6,907,252	$6,896,551.72	$10,592	$272.30	+$6.90M → HDGHF
2	$4,459,373,824	$4,451,983,064.22	$11,289	$357.73	+$4459.36M → HDGHF
3	$2,690,971,392,991	$2,686,199,862,999.76	$12,123	$472.89	+$2690971.38M → HDGHF
4	$1,517,799,501,371,570	$1,514,920,161,981,069.00	$13,141	$629.86	+$1517799501.36M → HDGHF
5	$800,190,923,014,392,800	$798,566,877,547,925,100.00	$14,408	$846.81	+$800190923014.38M → HDGHF
6	$394,321,769,154,895,900,000	$393,465,564,867,270,500,000.00	$16,021	$1,151.60	+$394321769154895.88M → HDGHF
7	$181,631,058,470,881,800,000,000	$181,209,134,177,886,080,000,000.00	$18,122	$1,588.22	+$181631058470881792.00M → HDGHF
8	$78,201,720,943,575,400,000,000,000	$78,007,375,711,011,540,000,000,000.00	$20,930	$2,228.20	+$78201720943575400448.00M → HDGHF
9	$31,472,719,690,937,434,000,000,000,000	$31,389,043,849,527,810,000,000,000,000.00	$24,792	$3,191.91	+$3.1472719690937433e+22M → HDGHF
10	$11,839,933,886,478,554,000,000,000,000,000	$11,806,258,076,409,250,000,000,000,000,000.00	$30,274	$4,689.40	+$1.1839933886478554e+25M → HDGHF

HDGHF vs JNJ: Complete Analysis 2026

HDGHF — Stock

Haydale Graphene Industries plc, through its subsidiaries, produces, sells, and functionalizes graphene and other nanomaterials in the United Kingdom, Europe, the United States, China, Thailand, South Korea, Japan, and internationally. It offers inks and coatings, resins, and fluids and masterbatches for use in composites and polymers; masterbatch and pre-preg composites, elastomers and other nanomaterials; and installed SiC. In addition, it provides graphene face masks; ceramycGuard; composites; elastomers; silicon carbide whiskers; and advanced consulting and test services. The company serves the aerospace, automotive, marine, medical, printing inks and coating, and sports industries. Haydale Graphene Industries plc was formerly known as Innovative Carbon Limited and changed its name to Haydale Graphene Industries plc in March 2014. The company was incorporated in 2010 and is headquartered in Ammanford, the United Kingdom.

Full HDGHF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this HDGHF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HDGHF vs SCHD HDGHF vs JEPI HDGHF vs O HDGHF vs KO HDGHF vs MAIN HDGHF vs ABBV HDGHF vs MRK HDGHF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.